SignatureFD’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.2K Buy
1,920
+1,854
+2,809% +$24.4K ﹤0.01% 2297
2026
Q2
$623 Buy
+66
New +$630 ﹤0.01% 3327
2025
Q2
– Sell
-834
Closed -$7.63K – 3285
2025
Q1
$7.63K Sell
834
-450
-35% -$4.5K ﹤0.01% 2462
2024
Q4
$13.5K Hold
1,284
– – ﹤0.01% 2248
2024
Q3
$15.3K Buy
+1,284
New +$11.1K ﹤0.01% 2166
2023
Q3
– Sell
-1,688
Closed -$4.88K – 3208
2023
Q2
$4.88K Buy
1,688
+844
+100% +$1.62K ﹤0.01% 2528
2023
Q1
$903 Hold
844
– – ﹤0.01% 3015
2022
Q4
$2.2K Hold
844
– – ﹤0.01% 2787
2022
Q3
$6K Sell
844
-523
-38% -$4.1K ﹤0.01% 2321
2022
Q2
$9K Buy
1,367
+221
+19% +$2.26K ﹤0.01% 2147
2022
Q1
$16K Sell
1,146
-26
-2% -$348 ﹤0.01% 1948
2021
Q4
$17K Buy
1,172
+1,115
+1,956% +$15.8K ﹤0.01% 1848
2021
Q3
$1K Buy
+57
New +$877 ﹤0.01% 2784

Other funds holding BVS

SignatureFD's BVS Position: Q3 2026 in Review

SignatureFD increased its Bioventus (BVS) stake by 2,809% in Q3 2026, buying an estimated $24.4K and bringing the position to 1,920 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

SignatureFD first reported a position in BVS in Q3 2021 and has held it in 13 quarters since. 36 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • SignatureFD held 1,920 shares of Bioventus worth $26.2K as of Q3 2026.
  • SignatureFD bought 1,854 Bioventus shares in Q3 2026, an estimated $24.4K.
  • Bioventus made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2297 holding.
  • SignatureFD first reported a position in Bioventus in Q3 2021 and has held it in 13 quarters since.
  • 36 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.